Wanbangde Pharmaceutical Holding Group Co Ltd (002082) — Cash Flow-to-Debt Ratio
Wanbangde Pharmaceutical Holding Group Co Ltd (002082) has a Cash Flow-to-Debt Ratio of 0.00x as of September 2025, meaning its operating cash flow of CN¥-1.04 Million could theoretically repay 0% of its total liabilities (CN¥1.78 Billion) in one year. See 002082 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Wanbangde Pharmaceutical Holding Group Co Ltd Cash Flow-to-Debt Ratio (2003–2025)
Historical debt coverage capacity for Wanbangde Pharmaceutical Holding Group Co Ltd across 23 annual periods. For the full cash flow conversion analysis, see 002082 cash flow metrics.
Annual Cash Flow-to-Debt Ratio for Wanbangde Pharmaceutical Holding Group Co Ltd (2003–2025)
Year-by-year debt coverage analysis for Wanbangde Pharmaceutical Holding Group Co Ltd. Check Wanbangde Pharmaceutical Holding Group C cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.34x | CN¥603.98 Million | CN¥1.78 Billion | ▲ +342.5% |
| 2024 | 0.08x | CN¥120.22 Million | CN¥1.57 Billion | ▲ +261.5% |
| 2023 | -0.05x | CN¥-72.87 Million | CN¥1.54 Billion | ▲ +72.4% |
| 2022 | -0.17x | CN¥-239.65 Million | CN¥1.40 Billion | ▼ -1364.0% |
| 2021 | 0.01x | CN¥22.09 Million | CN¥1.63 Billion | ▼ -74.8% |
| 2020 | 0.05x | CN¥151.01 Million | CN¥2.80 Billion | ▲ +140.9% |
| 2019 | -0.13x | CN¥-248.69 Million | CN¥1.89 Billion | ▼ -209.1% |
| 2018 | 0.12x | CN¥135.40 Million | CN¥1.12 Billion | ▲ +440.5% |
| 2017 | -0.04x | CN¥-17.60 Million | CN¥496.58 Million | ▼ -103.0% |
| 2016 | 1.19x | CN¥310.71 Million | CN¥261.85 Million | ▲ +1813.3% |
| 2015 | 0.06x | CN¥16.76 Million | CN¥270.28 Million | ▼ -88.7% |
| 2014 | 0.55x | CN¥140.31 Million | CN¥254.69 Million | ▼ -15.1% |
| 2013 | 0.65x | CN¥234.35 Million | CN¥361.07 Million | ▲ +50.2% |
| 2012 | 0.43x | CN¥202.73 Million | CN¥469.09 Million | ▲ +11897.2% |
| 2011 | 0.00x | CN¥-1.44 Million | CN¥392.22 Million | ▼ -100.9% |
| 2010 | 0.43x | CN¥162.26 Million | CN¥380.46 Million | ▲ +92.4% |
| 2009 | 0.22x | CN¥68.13 Million | CN¥307.39 Million | ▼ -72.9% |
| 2008 | 0.82x | CN¥253.06 Million | CN¥309.46 Million | ▲ +3265.4% |
| 2007 | 0.02x | CN¥12.45 Million | CN¥512.51 Million | ▲ +242.8% |
| 2006 | 0.01x | CN¥3.50 Million | CN¥493.85 Million | ▼ -67.9% |
| 2005 | 0.02x | CN¥11.23 Million | CN¥508.84 Million | ▼ -81.1% |
| 2004 | 0.12x | CN¥32.69 Million | CN¥280.48 Million | ▼ -48.7% |
| 2003 | 0.23x | CN¥37.01 Million | CN¥163.05 Million | — |